美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cyclerion Therapeutics, Inc.

26.20

+2.6811.39%

盘前：26.200.00000.00%04:01 EDT

成交量：2.80万

成交额：65.59万

市值：1,752.26万

市盈率：-2.16

高：26.20

开：21.20

低：21.00

收：23.52

52周最高：59.36

52周最低：7.19

股本：66.88万

流通股本：24.07万

量比：1.05

换手率：11.64%

股息：- -

股息率：- -

每股收益(TTM):-12.1293

每股收益(LYR):-7.7700

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):-3.37

数据加载中...

总览公司新闻公告

公司资料

公司名字：

Cyclerion Therapeutics, Inc.

交易所：

NASDAQ

成立时间：

2024

员工人数：

- -

公司地址：

221 Crescent Street,Building 23,Suite 105,Waltham,Massachusetts,United States

官网：

http://www.cyclerion.com

邮编：

02453

电话：

传真：

- -

简介：

Cyclerion Therapeutics, Inc.于2018年9月6日在马萨诸塞州注册成立。Cyclerion是一家生物制药公司，专注于在中枢神经系统和外周使用新型可溶性鸟苷酸环化酶刺激剂治疗严重疾病。一氧化氮sGC环鸟苷一磷酸信号通路是精确控制全身生理关键方面的根本机制。NO-SGC-cGMP通路调节CNS和外周的多种关键生物学功能，已成功地被几种药物靶向。

董事

名称

职位

Jonathan Violin

Chief Executive Officer and Director and President

Andrew Gottesdiener

Director

Heidi Henson

Director

Michelle Pernice

Director

Nimish Shah

Director

Tomas Kiselak

Director

股东

名称

职位

Jonathan Violin

Chief Executive Officer and Director and President

Mark Vignola

Chief Financial Officer

Madelyn Zeylikman

General Counsel and Secretary

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/KRSA/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KRSA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRSA\",,,,,undefined,":{"symbol":"KRSA","market":"US","secType":"STK","nameCN":"Cyclerion Therapeutics, Inc.","latestPrice":26.2,"timestamp":1788984000000,"preClose":23.52,"halted":0,"volume":28025,"hourTrading":{"tag":"盘前","latestPrice":26.2,"preClose":26.2,"latestTime":"04:01 EDT","volume":30,"amount":783,"timestamp":1789027262863,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.1139455782312925,"floatShares":240679,"shares":668800,"eps":-12.129334,"marketStatus":"盘前交易","change":2.68,"latestTime":"09-10 04:27:00 EDT","open":21.2,"high":26.2,"low":21.0001,"amount":655933.168175,"amplitude":0.221084,"askPrice":28.98,"askSize":100,"bidPrice":17.38,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-12.129334,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789047000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":26.2,"preHourTrading":{"tag":"盘前","latestPrice":26.2,"preClose":26.2,"latestTime":"04:01 EDT","volume":30,"amount":783,"timestamp":1789027262863,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":24.26,"preClose":26.2,"latestTime":"19:55 EDT","volume":1463,"amount":37015.4622,"timestamp":1788998115597,"change":-1.94,"changeRate":-0.074046,"amplitude":0.074046},"volumeRatio":1.0546974918121717},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRSA\",,,,,undefined,":{"symbol":"KRSA","floatShares":240679,"roa":"--","roe":"--","lyrEps":-7.77,"volumeRatio":1.0546974918121717,"shares":668800,"dividePrice":0,"high":26.2,"amplitude":0.221084,"preClose":23.52,"low":21.0001,"week52Low":7.1862,"pbRate":"--","week52High":59.36,"institutionHeld":0,"latestPrice":26.2,"eps":-12.129334,"divideRate":0,"volume":28025,"delay":0,"ttmEps":-12.129334,"open":21.2,"prevYearClose":1.27,"prevWeekClose":4.25,"prevMonthClose":3.68,"prevQuarterClose":3.39,"fiveDayClose":4.17,"twentyDayClose":3.57,"sixtyDayClose":3.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KRSA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-09-09","symbol":"KRSA","defaultRemindTime":1788960600000,"type":"split","dateTimestamp":1788926400000,"forFactor":7,"toFactor":1,"ratio":7}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KRSA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KRSA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1966002000,"yearFounded":2024,"address":"221 Crescent Street,Building 23,Suite 105,Waltham,Massachusetts,United States","zipCode":"02453","officePhone":"(781) 516-2325"},"stockCompanyDetail":{"websiteUrl":"http://www.cyclerion.com","stockEarnings":[{"period":"1week","weight":4.7965},{"period":"1month","weight":6.3184},{"period":"3month","weight":7.162},{"period":"6month","weight":17.069},{"period":"1year","weight":9.0769},{"period":"ytd","weight":19.6299}],"compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0138},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1512},{"period":"1year","weight":0.1723},{"period":"ytd","weight":0.118}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cyclerion Therapeutics, Inc.于2018年9月6日在马萨诸塞州注册成立。Cyclerion是一家生物制药公司，专注于在中枢神经系统和外周使用新型可溶性鸟苷酸环化酶刺激剂治疗严重疾病。一氧化氮sGC环鸟苷一磷酸信号通路是精确控制全身生理关键方面的根本机制。NO-SGC-cGMP通路调节CNS和外周的多种关键生物学功能，已成功地被几种药物靶向。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.030269},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.005726},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.111354},{"month":4,"riseRate":0.428571,"avgChangeRate":0.134457},{"month":5,"riseRate":0.25,"avgChangeRate":-0.02829},{"month":6,"riseRate":0.5,"avgChangeRate":0.038893},{"month":7,"riseRate":0.375,"avgChangeRate":0.026358},{"month":8,"riseRate":0.625,"avgChangeRate":0.100341},{"month":9,"riseRate":0.375,"avgChangeRate":0.746845},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.324291},{"month":11,"riseRate":0.285714,"avgChangeRate":0.0186},{"month":12,"riseRate":0.428571,"avgChangeRate":0.106805}],"exchange":"NASDAQ","name":"Cyclerion Therapeutics, Inc.","nameEN":"Cyclerion Therapeutics, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"KRSA\",market:\"US\",,,undefined,":{"directors":[{"name":"Jonathan Violin","position":"Chief Executive Officer and Director and President"},{"name":"Andrew Gottesdiener","position":"Director"},{"name":"Heidi Henson","position":"Director"},{"name":"Michelle Pernice","position":"Director"},{"name":"Nimish Shah","position":"Director"},{"name":"Tomas Kiselak","position":"Director"}],"executives":[{"name":"Jonathan Violin","position":"Chief Executive Officer and Director and President"},{"name":"Mark Vignola","position":"Chief Financial Officer"},{"name":"Madelyn Zeylikman","position":"General Counsel and Secretary"}]}}}